Skip to content
value.today

Scynexis Inc.

Formerly Scyrex, Inc.

Total raised
$11 M
1 round on record
Latest round
$11 M
Dec 2011
First round on record
Dec 2011
Today
Went public
See the company page

Scynexis Inc. is listed today as Scynexis, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Scynexis Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2011$11 MNo. 1$10 to $50 million

Scynexis Inc.: Raise no. 1, Dec 2011

Investors in this round

11 investors had bought by the notice of May 18, 2012: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Scynexis Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$11 M of $15 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian J. Schwab · Executive Officer
  • Charles F. Osborne, Jr. · Executive Officer
  • Yves J. Ribeill · Executive Officer, Director
  • Ann F. Hanham · Director
  • Ed J. Penhoet · Director
  • Jean-Yves F. Nothias · Director
  • Jose F. Barella · Director
  • Laurent F. Arthaud · Director
  • Mounia F. Chaoui · Director
  • Pamela J. Kirby · Director
  • Patrick J. Langlois · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian J. Schwab, Chief Licensing Officer and General Counsel. Source: SEC Form D and 2 amendments, newest notice filed May 18, 2012. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Scynexis, Inc., its revenue in fiscal 2025 came from these product and service lines: License Agreement Revenue $19.16 million (93%).

    Annual report (SEC XBRL) · Dec 2025

  • Scynexis Inc. chose not to state its revenue in its newest notice of a funding round (May 2012).

    SEC Form D · May 2012

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · May 2012

Products and services#

No products or services of Scynexis Inc. are on record.

Investors#

8 named in official filings. Open an investor to see everything it has backed.

Investors in Scynexis Inc.
InvestorKindAmountRoundRoleSource
Alta Biopharma Management II LLCFund or asset managernot statednot statedHeld Series C, D-1 and D-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Alta Biopharma Partners II LPFund or asset managernot statednot statedHeld Series C, D-1 and D-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Alta Embarcadero Biopharma Partners II LLCFund or asset managernot statednot statedHeld Series C, D-1 and D-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
FCPR Biotechnology FundFund or asset managernot statednot statedHeld Series B, C, D-1 and D-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Genavent F.c.p.r.Personnot statednot statedHeld Series B, C, D-1 and D-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Pamela J. KirbyPersonnot statednot statedHeld Series D-2 preferred stock, director (Form 3, 2014)SEC Form 3
Ventech Capital IIFund or asset managernot statednot statedHeld Series B, C, D-1 and D-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Yves J. RibeillPersonnot statednot statedHeld Series D-2 preferred stock, director (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 11 investors.

Largest shareholders today

Institutions holding Scynexis, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Scynexis Inc.
NameRoleNamed in
Brian J. SchwabExecutive officerMay 2012
Charles F. Osborne, Jr.Executive officerMay 2012
Yves J. RibeillExecutive officerMay 2012
Ann F. HanhamDirectorMay 2012
Ed J. PenhoetDirectorMay 2012
Jean-Yves F. NothiasDirectorMay 2012
Jose F. BarellaDirectorMay 2012
Laurent F. ArthaudDirectorMay 2012
Mounia F. ChaouiDirectorMay 2012
Pamela J. KirbyDirectorMay 2012
Patrick J. LangloisDirectorMay 2012
Yves J. RibeillDirectorMay 2012
Horace D. NalleDirectorFeb 2012
Mounia D. ChaouiDirectorFeb 2012

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.